204 related articles for article (PubMed ID: 14615453)
1. Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients.
Marec-Berard P; Blay JY; Schell M; Buclon M; Demaret C; Ray-Coquard I
J Clin Oncol; 2003 Nov; 21(22):4235-8. PubMed ID: 14615453
[TBL] [Abstract][Full Text] [Related]
2. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
[TBL] [Abstract][Full Text] [Related]
3. Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.
Ray-Coquard I; Le Cesne A; Rubio MT; Mermet J; Maugard C; Ravaud A; Chevreau C; Sebban C; Bachelot T; Biron P; Blay JY
J Clin Oncol; 1999 Sep; 17(9):2840-6. PubMed ID: 10561360
[TBL] [Abstract][Full Text] [Related]
4. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.
Wu Y; Aravind S; Ranganathan G; Martin A; Nalysnyk L
Clin Ther; 2009; 31 Pt 2():2416-32. PubMed ID: 20110050
[TBL] [Abstract][Full Text] [Related]
5. An epidemiological review of red cell transfusions in cancer chemotherapy.
Skillings JR; Rogers-Melamed I; Nabholtz JM; Sawka C; Gwadry-Sridhar F; Moquin JP; Rubinger M; Ganguly P; Burnell M; Shustik C; Dryer D; McLaughlin M; White D
Cancer Prev Control; 1999 Jun; 3(3):207-12. PubMed ID: 10474769
[TBL] [Abstract][Full Text] [Related]
6. A retrospective review of blood transfusions in cancer patients with anemia.
Estrin JT; Schocket L; Kregenow R; Henry DH
Oncologist; 1999; 4(4):318-24. PubMed ID: 10476543
[TBL] [Abstract][Full Text] [Related]
7. Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.
Ray-Coquard I; Ghesquière H; Bachelot T; Borg C; Biron P; Sebban C; LeCesne A; Chauvin F; Blay JY;
Br J Cancer; 2001 Sep; 85(6):816-22. PubMed ID: 11556830
[TBL] [Abstract][Full Text] [Related]
8. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
9. [Anemia and chemotherapy].
Ray-Coquard I; Bachelot T; Sebban C; Biron P; Guastalla JP; Blay JY
Bull Cancer; 2003 Apr; 90 Spec No():S133-43. PubMed ID: 12856425
[TBL] [Abstract][Full Text] [Related]
10. Cancer anemia survey in Division of Medical Oncology at Siriraj Hospital (CAS).
Ithimakin S; Srimuninnimit V
J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S110-8. PubMed ID: 19562994
[TBL] [Abstract][Full Text] [Related]
11. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma.
Tanvetyanon T; Choudhury AM
Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
14. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
15. Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?
Liet JM; Paranon S; Baraton L; Dejode JM; Rozé JC
Pediatr Crit Care Med; 2006 Nov; 7(6):541-4. PubMed ID: 17006380
[TBL] [Abstract][Full Text] [Related]
16. Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial.
Wagner LM; Billups CA; Furman WL; Rao BN; Santana VM
J Clin Oncol; 2004 May; 22(10):1886-93. PubMed ID: 15143081
[TBL] [Abstract][Full Text] [Related]
17. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
18. Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction.
Aronson D; Dann EJ; Bonstein L; Blich M; Kapeliovich M; Beyar R; Markiewicz W; Hammerman H
Am J Cardiol; 2008 Jul; 102(2):115-9. PubMed ID: 18602505
[TBL] [Abstract][Full Text] [Related]
19. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants.
Madan A; Kumar R; Adams MM; Benitz WE; Geaghan SM; Widness JA
J Perinatol; 2005 Jan; 25(1):21-5. PubMed ID: 15496875
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
